Literature DB >> 3987778

Relationship between lipid composition and drug metabolizing capacity of human liver.

M J Savolainen, A J Arranto, I E Hassinen, P V Luoma, R O Pelkonen, E A Sotaniemi.   

Abstract

The relationship between hepatic glycerolipids and microsomal drug-metabolizing enzymes was studied in liver biopsies from 41 subjects. The series included obese, diabetic, epileptic and chronic alcoholic patients, all of whom were hospitalized for suspected hepatic ailments (fatty liver, hepatitis or cirrhosis). Therapy with enzyme-inducing anticonvulsants was associated with high phospholipid and cytochrome P-450 and low triacylglycerol concentration in the liver. In patients with fatty liver or cirrhosis low phospholipid and cytochrome P-450 and high triacylglycerol concentrations were observed. There was a significant correlation (r (Pearson's product moment correlation coefficient) = 0.91) between the hepatic phospholipid and cytochrome P-450 concentration. The cytochrome P-450 concentration was inversely related (r = -0.74) to the triacylglycerol concentration. The positive correlation between hepatic phospholipids and drug-metabolizing enzymes could be interpreted as indicating that in human liver phospholipid and cytochrome P-450 synthesis share common regulators, or that phospholipids are necessary for the maximum rate of cytochrome P-450 synthesis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3987778     DOI: 10.1007/bf00547057

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  33 in total

1.  A possible metabolic explanation for drug-induced phospholipidosis.

Authors:  R H Michell; D Allan; M Bowley; D N Brindley
Journal:  J Pharm Pharmacol       Date:  1976-04       Impact factor: 3.765

2.  [Enzyme induction and increase of endoplasmic reticulum in liver cells during phenobarbital (Luminal) therapy].

Authors:  H REMMER; H J MERKER
Journal:  Klin Wochenschr       Date:  1963-03-15

3.  Reduced response to phenobarbital by the liver of rats fed a choline-deficient diet.

Authors:  R Saito; L W Estes; B Lombardi
Journal:  Biochim Biophys Acta       Date:  1975-01-13

Review 4.  Lipidosis induced by amphiphilic cationic drugs.

Authors:  H Lüllmann; R Lüllmann-Rauch; O Wassermann
Journal:  Biochem Pharmacol       Date:  1978       Impact factor: 5.858

5.  Liver lipid content in alcoholics.

Authors:  A Lundquist; T Wiebe; P Belfrage
Journal:  Acta Med Scand       Date:  1973-12

6.  Plasma high-density lipoproteins and liver lipids and proteins in man. Relation to hepatic histology and microsomal enzyme induction.

Authors:  P V Luoma; M J Savolainen; E A Sotaniemi; R O Pelkonen; A J Arranto; C Ehnholm
Journal:  Acta Med Scand       Date:  1983

7.  Treatment of alcoholic cirrhosis with enzyme inducers.

Authors:  A Rautio; E A Sotaniemi; R O Pelkonen; P V Luoma
Journal:  Clin Pharmacol Ther       Date:  1980-11       Impact factor: 6.875

8.  The evaluation of the drug-metabolizing capacity in patients with diabetes mellitus.

Authors:  P I Salmela; E A Sotaniemi; R O Pelkonen
Journal:  Diabetes       Date:  1980-10       Impact factor: 9.461

9.  Effects of phenobarbital upon triacylglycerol metabolism in the rabbit.

Authors:  D M Goldberg; M W Roomi; A Yu; D A Roncari
Journal:  Biochem J       Date:  1980-10-15       Impact factor: 3.857

10.  Phenobarbital-induced alterations in phosphatidylcholine and triglyceride synthesis in hepatic endoplasmic reticulum.

Authors:  D L Young; G Powell; W O McMillan
Journal:  J Lipid Res       Date:  1971-01       Impact factor: 5.922

View more
  7 in total

1.  Nutritional factors of microsomal enzymatic induction: influence of lipidic components of the diet.

Authors:  J Mounie; H Goudonnet; C Prevost; L Champion; R C Truchot; A Escousse
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Oct-Dec       Impact factor: 2.441

2.  Lipids and delta6-desaturase activity alterations in rat liver microsomal membranes induced by fumonisin B1.

Authors:  W C A Gelderblom; W Moritz; S Swanevelder; C M Smuts; S Abel
Journal:  Lipids       Date:  2002-09       Impact factor: 1.880

Review 3.  Gene activation regresses atherosclerosis, promotes health, and enhances longevity.

Authors:  Pauli V Luoma
Journal:  Lipids Health Dis       Date:  2010-07-06       Impact factor: 3.876

4.  The effect of liver microsomal enzyme inducing and inhibiting drugs on insulin mediated glucose metabolism in man.

Authors:  J T Lahtela; B Gachalyi; S Eksymä; A Hämäläinen; E A Sotaniemi
Journal:  Br J Clin Pharmacol       Date:  1986-01       Impact factor: 4.335

5.  Relevance of Liver Failure for Anti-Infective Agents: From Pharmacokinetic Alterations to Dosage Adjustments.

Authors:  Fiona V Bϋdingen; Daniel Gonzalez; Amelia N Tucker; Hartmut Derendorf
Journal:  Ther Adv Infect Dis       Date:  2014-02-01

Review 6.  Gene-activation mechanisms in the regression of atherosclerosis, elimination of diabetes type 2, and prevention of dementia.

Authors:  P V Luoma
Journal:  Curr Mol Med       Date:  2011-07       Impact factor: 2.222

Review 7.  Elimination of endoplasmic reticulum stress and cardiovascular, type 2 diabetic, and other metabolic diseases.

Authors:  Pauli V Luoma
Journal:  Ann Med       Date:  2012-08-28       Impact factor: 4.709

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.